Literature DB >> 30398603

Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.

Joung Sik Son1, Seulggie Choi2, Kyuwoong Kim2, Sung Min Kim2, Daein Choi3, Gyeongsil Lee4, Su-Min Jeong1, Seong Yong Park5, Yeon-Yong Kim5, Jae-Moon Yun1, Sang Min Park1,2.   

Abstract

Importance: Among young adults, the association of the 2017 American College of Cardiology/American Heart Association (ACC/AHA) High Blood Pressure Clinical Practice Guidelines with risk of cardiovascular disease (CVD) later in life is uncertain. Objective: To determine the association of blood pressure categories before age 40 years with risk of CVD later in life. Design, Setting, and Participants: This population-based cohort study from the Korean National Health Insurance Service consisted of 2 488 101 adults aged 20 through 39 years with blood pressure measurements taken twice from 2002 through 2005. Starting from January 1, 2006, participants were followed up until the date of CVD diagnosis, death, or December 31, 2015. Exposures: Participants were categorized by blood pressure readings: normal (systolic, <120 mm Hg; diastolic, <80 mm Hg), elevated (sytolic, 120-129 mm Hg; diastolic, <80 mm Hg), stage 1 hypertension (systolic, 130-139 mm Hg; diastolic, 80-89 mm Hg), and stage 2 hypertension (systolic, ≥140 mm Hg; diastolic, ≥90 mm Hg). Main Outcomes and Measures: The primary outcome was CVD defined as 2 or more days of hospitalization due to CVD or death due to CVD. The secondary outcomes were coronary heart disease (CHD) and stroke.
Results: The study population consisted of 2 488 101 participants (median age, 31 years [interquartile range, 27-36 years], 789 870 women [31.7%]). A total of 44 813 CVD events were observed during a median follow-up duration of 10 years. Men with baseline stage 1 hypertension compared with those with normal blood pressure had higher risk of CVD (incidence, 215 vs 164 per 100 000 person-years; difference, 51 per 100 000 person-years [95% CI, 48-55]; adjusted hazard ratio [HR], 1.25 [95% CI, 1.21-1.28]), CHD (incidence, 134 vs 103 per 100 000 person-years; difference, 31 per 100 000 person-years [95% CI, 28-33]; adjusted HR, 1.23 [95% CI, 1.19-1.27]), and stroke (incidence, 90 vs 67 per 100 000 person-years; difference, 23 per 100 000 person-years [95% CI, 21-26]; adjusted HR, 1.30 [95% CI, 1.25-1.36]). Women with baseline stage 1 hypertension compared with those with normal blood pressure had increased risk of CVD (incidence, 131 vs 91 per 100 000 person-years; difference, 40 per 100 000 person-years [95% CI, 35-45]; adjusted HR, 1.27 [95% CI, 1.21-1.34]), CHD (incidence, 56 vs 42 per 100 000 person-years; difference, 14 per 100 000 person-years [95% CI, 11-18]; adjusted HR, 1.16 [95% CI, 1.08-1.25]), and stroke (incidence, 79 vs 51 per 100 000 person-years; difference, 28 per 100 000 person-years [95% CI, 24-32]; adjusted HR [1.37, 95% CI, 1.29-1.46]). Results for state 2 hypertension were consistent. Conclusions and Relevance: Among Korean young adults, stage 1 and stage 2 hypertension, compared with normal blood pressure, were associated with increased risk of subsequent cardiovascular disease events. Young adults with hypertension, defined by the 2017 ACC/AHA criteria, may be at increased risk of cardiovascular disease.

Entities:  

Mesh:

Year:  2018        PMID: 30398603      PMCID: PMC6248107          DOI: 10.1001/jama.2018.16501

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  33 in total

1.  Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry.

Authors:  K Miura; M L Daviglus; A R Dyer; K Liu; D B Garside; J Stamler; P Greenland
Journal:  Arch Intern Med       Date:  2001-06-25

2.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

3.  Blood pressure in young adulthood and mortality from cardiovascular disease.

Authors:  P McCarron; G D Smith; M Okasha; J McEwen
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

4.  Prehypertension and cardiovascular disease risk in the Women's Health Initiative.

Authors:  Judith Hsia; Karen L Margolis; Charles B Eaton; Nanette K Wenger; Matthew Allison; LieLing Wu; Andrea Z LaCroix; Henry R Black
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

5.  Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region.

Authors:  Hisatomi Arima; Yoshitaka Murakami; Tai Hing Lam; Hyeon Chang Kim; Hirotsugu Ueshima; Jean Woo; Il Suh; Xianghua Fang; Mark Woodward
Journal:  Hypertension       Date:  2012-04-30       Impact factor: 10.190

Review 6.  Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies.

Authors:  Xiaofan Guo; Xiaoyu Zhang; Liang Guo; Zhao Li; Liqiang Zheng; Shasha Yu; Hongmei Yang; Xinghu Zhou; Xingang Zhang; Zhaoqing Sun; Jue Li; Yingxian Sun
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

7.  Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies.

Authors:  Yoshitaka Murakami; Atsushi Hozawa; Tomonori Okamura; Hirotsugu Ueshima
Journal:  Hypertension       Date:  2008-04-28       Impact factor: 10.190

8.  Prehypertension and incidence of cardiovascular disease: a meta-analysis.

Authors:  Yuli Huang; Sheng Wang; Xiaoyan Cai; Weiyi Mai; Yunzhao Hu; Hongfeng Tang; Dingli Xu
Journal:  BMC Med       Date:  2013-08-02       Impact factor: 8.775

9.  Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis.

Authors:  Yuli Huang; Xiaoyan Cai; Changhua Liu; Dingji Zhu; Jinghai Hua; Yunzhao Hu; Jian Peng; Dingli Xu
Journal:  J Am Heart Assoc       Date:  2015-02-19       Impact factor: 5.501

10.  2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.

Authors:  Lisandro D Colantonio; John N Booth; Adam P Bress; Paul K Whelton; Daichi Shimbo; Emily B Levitan; George Howard; Monika M Safford; Paul Muntner
Journal:  J Am Coll Cardiol       Date:  2018-09-11       Impact factor: 24.094

View more
  57 in total

1.  Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the 2017 Hypertension Clinical Practice Guidelines.

Authors:  Yan-Feng Zhou; Na Liu; Pei Wang; Jae Jeong Yang; Xing-Yue Song; Xiong-Fei Pan; Xiaomin Zhang; Meian He; Honglan Li; Yu-Tang Gao; Yong-Bing Xiang; Tangchun Wu; Danxia Yu; An Pan
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

2.  Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study.

Authors:  Elena Critselis; Christina Chrysohoou; Natasa Kollia; Ekavi N Georgousopoulou; Dimitrios Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  J Hum Hypertens       Date:  2019-02-11       Impact factor: 3.012

Review 3.  Prevalence of high blood pressure under 2017 ACC/AHA guidelines: a systematic review and meta-analysis.

Authors:  Peisheng Xiong; Zhixi Liu; Meijuan Xiong; Feng Xie
Journal:  J Hum Hypertens       Date:  2020-12-08       Impact factor: 3.012

4.  Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS).

Authors:  Mohammad Saatchi; Mohammad Ali Mansournia; Davood Khalili; Rajabali Daroudi; Kamran Yazdani
Journal:  Risk Manag Healthc Policy       Date:  2020-08-05

5.  Association between metabolic syndrome and gestational diabetes mellitus in women and their children: a systematic review and meta-analysis.

Authors:  Maleesa M Pathirana; Zohra S Lassi; Anna Ali; Margaret A Arstall; Claire T Roberts; Prabha H Andraweera
Journal:  Endocrine       Date:  2020-09-15       Impact factor: 3.633

6.  Could arterial stiffness be early reversible target organ damage test in childhood hypertension?

Authors:  Duygu Övünç Hacıhamdioğlu; Özben Ceylan; Aytül Hande Yardımcı
Journal:  Anatol J Cardiol       Date:  2021-07       Impact factor: 1.596

7.  Cardiovascular Risk Factors Across the Life Course and Cognitive Decline: A Pooled Cohort Study.

Authors:  Kristine Yaffe; Eric Vittinghoff; Tina Hoang; Karen Matthews; Sherita H Golden; Adina Zeki Al Hazzouri
Journal:  Neurology       Date:  2021-03-17       Impact factor: 9.910

8.  Ten-year trends of hypertension treatment and control rate in Korea.

Authors:  Kwang-Il Kim; Eunjeong Ji; Jung-Yeon Choi; Sun-Wook Kim; Soyeon Ahn; Cheol-Ho Kim
Journal:  Sci Rep       Date:  2021-03-26       Impact factor: 4.379

9.  Associations of hypertension burden on subsequent dementia: a population-based cohort study.

Authors:  Hyunjean Jung; Pil-Sung Yang; Daehoon Kim; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jung-Hoon Sung; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

10.  Association between socioeconomic position and diabetic foot ulcer outcomes: a population-based cohort study in South Korea.

Authors:  Jeong Hyun Ha; Heejin Jin; Ji-Ung Park
Journal:  BMC Public Health       Date:  2021-07-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.